Antigen-based therapies targeting the expansion of regulatory T cells in autoimmune and allergic disease

Chemical Immunology and Allergy

Volumn 94, Issue , 2008, Pages 201-210

  Leech, M ^a   Anderton, S ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERED PEPTIDE LIGAND; ALUMINUM POTASSIUM SULFATE; ANTIGEN; AUTOANTIGEN; BASILIXIMAB; BET V 1 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FEL D 1 ANTIGEN; FREUND ADJUVANT; GAMMA INTERFERON; HISTAMINE H4 RECEPTOR; HOUSE DUST ALLERGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN; OVALBUMIN; PEANUT EXTRACT; PEPTIDE; PEPTIDE ANTIBODY; PLANT EXTRACT; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC ENCEPHALOMYELITIS; ANAPHYLAXIS; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; LOW DRUG DOSE; LYMPHOCYTE DEPLETION; NONHUMAN; PEANUT; PEPTIDE IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL;

ALLERGENS; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CELL PROLIFERATION; DESENSITIZATION, IMMUNOLOGIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES, REGULATORY; TH2 CELLS; VACCINATION;

EID: 52249097625     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000155088     Document Type: Review

References (31)

1. Bettelli E, Oukka M, Kuchroo VK: Th17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-350.
2. Romagnani S: The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399-408.
3. Perkins C, Wills-Karp M, Finkelman FD: IL-4 induces IL-13-independent allergic airway inflammation. J Allergy Clin Immunol 2006;118:410-419.
4. Miller SD, Turley DM, Podojil JR: Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol 2007;7:665-677.
5. Larche M, Wraith DC: Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005;11: S69-76.
6. Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6:345-352.
7. McGeachy MJ, Stephens LA, Anderton SM: Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 2005;175:3025-3032.
8. Leech MD, Benson RA, deVries A, Fitch PM, Howie SEM: Resolution of Der p 1-induced allergic airway inflammation is dependent on CD4+ CD25+ Foxp3+ regulatory cells. J Immunol 2007;179:7050-7058.
9. Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA: Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 2005;175:3053-3059.
10. Oldfield WL, Larche M, Kay AB: Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002;360:47-53.
11. Hochweller K, Sweenie CH, Anderton SM: Immunological tolerance using synthetic peptides - basic mechanisms and clinical application. Curr Mol Med 2006;6:631-643.
12. Faria AM, Weiner HL: Oral tolerance and TGF-β-producing cells. Inflamm Allergy Drug Targets 2006;5:179-190.
13. Larche M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006;6:761-771.
14. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K: Role of interleukin-10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
15. Verhoef A, Alexander C, Kay AB, Larche M: T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med 2005;2:e78.
16. Anderton SM, Wraith DC: Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol 1998;28:1251-1261.
17. Nicolson KS, O'Neill EJ, Sundstedt A, Streeter HB, Minaee S, Wraith DC: Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function. J Immunol 2006;176:5329-5337.
18. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H: Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005;6:1219-1227.
19. Zuleger CL, Gao X, Burger MS, Chu Q, Payne LG, Chen D: Peptide induces CD4+CD25+ and IL-10+ T cells and protection in airway allergy models. Vaccine 2005;23:3181-3186.
20. McCue D, Ryan K, Wraith DC, Anderton SM: Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cells repertoire. J Neuroimmunol 2004;156:96-106.
21. Van Wijk F, Wehrens EJ, Nierkens S, Boon L, Kasran A, Pieters R, Knippels LM: CD4+CD25+ T cells regulate the intensity of hypersensitivity responses to peanut, but are not decisive in the induction of oral sensitization. Clin Exp Allergy 2007;37:572-581.
22. Joetham A, Takeda K, Taube C, Miyahara N, Matsubara S, Koya T, Rha YH, Dakhama A, Gelfand EW: Naturally occurring lung CD4+CD25+ T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β. J Immunol 2007;178:1433-1442.
23. Gardner LM, Thien FC, Douglass JA, Rolland JM, O'Hehir RE: Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy 2004;34:1209-1219.
24. Tarzi M, Klunker S, Texier C, Verhoef A, Stapel SO, Akdis CA, Maillere B, Kay AB, Larche M: Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 2006;36:465-474.
25. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007;120:707-713.l
26. O'Garra A, Vieira P: Th1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007;7:425-428.
27. Leech MD, Chung C-Y, Culshaw A, Anderton SM: Peptide-based immunotherapy of CNS autoimmune disease without anaphylaxis. Eur J Immunol 2007;37:3576-3581.
28. Morgan RK, McAllister B, Cross L, Green DS, Kornfeld H, Center DM, Cruikshank WW: Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model. J Immunol 2007;178:8081-8089.
29. Kang HK, Liu M, Datta SK: Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 2007;178:7849-7858.
30. Nagato T, Kobayashi H, Yanai M, Sato K, Aoki N, Oikawa K, Kimura S, Abe Y, Celis E, Harabuchi Y, Tateno M: Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells. J Immunol 2007;178:1189-1198.
31. O'Connor RA, Malpass KH, Anderton SM: The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J Immunol 2007;179:958-966.